| Long name: |
PRAME Polyclonal Antibody |
| Antigen: |
PRAME |
| Synonim names: |
CT130, OIP-4, OIP4, MAPE |
| Other names: |
Melanoma antigen preferentially expressed in tumors, OIP-4, Opa-interacting protein 4, Opa-interacting protein OIP4, Preferentially expressed antigen of melanoma, cancer/testis antigen 130, melanoma antigen preferentially expressed in tumors, opa-interacting protein 4, preferentially expressed antigen in melanoma, preferentially expressed antigen of melanoma, Melanoma antigen preferentially expressed in tumors |
| Gene name: |
PRAME, PRAME |
| Gene synonims: |
CT130, MAPE, MAPE, OIP-4, OIP-4, OIP4, OIP4, PRAME, PRAME |
| Category: |
Antibodies |
| Clonality: |
Polyclonal Antibodies |
| Clone: |
Not applicable to Polyclonal Antibodies |
| Reacts with: |
Human (Homo sapiens) |
| Specificity: |
PRAME, This is an antibody designed to detect PRAME |
| Purification method: |
Affinity Purification |
| Concentration: |
1mg/ml |
| Storage, shipping and handling: |
Avoid cycles of freezing and thawing as they may denaturate the polypeptide chains of the antibody, Due to transportation or handling reasons, For longer periods of time we recommend keeping the vial frozen at -40 or -80, Upon receving, We recommend you to briefly cetrifuge the vial prior to use to gather the content on the bottom, freeze at -20, small amounts of the antibody might get caught on the lid or walls of the vial, The antibody is shipped at +4 degrees Celsius |
| Applications: |
Immunofluorescence (IF), Immunohistochemistry (IHC), Western Blot (WB) |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by MBS Polyclonals they should be stored frozen at - 24° |
| Gene target: |
PRAME |
| Short name: |
Anti- PRAME Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
Antibody to preferentially expressed antigen in melanoma (Antibody to) |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
CT130 and MAPE and OIP-4 and OIP4, DNA-templated and biological process this GO :0006915 and apoptotic process and biological process this GO :0008284 and positive regulation of cell proliferation and biological process this GO :0030154 and cell differentiation and biological process this GO :0040008 and regulation of growth and biological process this GO :0042974 and retinoic acid receptor binding and molecular function this GO :0043066 and negative regulation of apoptotic process and biological process this GO :0045596 and negative regulation of cell differentiation and biological process this GO :0045892 and negative regulation of transcription, DNA-templated and biological process this GO :0048387 and negative regulation of retinoic acid receptor signaling pathway and biological process, PRAME and IDBG-2240 and ENSG00000185686 and 23532, nuclei, retinoic acid receptor binding, this GO :0005515 and protein binding and molecular function this GO :0005634 and nucleus and cellular component this GO :0005886 and plasma membrane and cellular component this GO :0006351 and transcription, this GO :0005515 : protein binding, this GO :0005515 : protein binding and also this GO :0042974 : retinoic acid receptor binding, this GO :0042974 : retinoic acid receptor binding, preferentially expressed antigen in melanoma |
| Identity: |
9336 |
| Gene: |
PRAME |
More about : PRAME |
| Long gene name: |
preferentially expressed antigen in melanoma |
| Synonyms gene: |
MAPE |
| Synonyms: |
CT130 |
| Synonyms name: |
cancer/testis antigen 130 |
| Locus: |
22q11, 22 |
| Discovery year: |
1996-06-21 |
| GenBank acession: |
U65011 |
| Entrez gene record: |
23532 |
| Pubmed identfication: |
9047241 10591208 |
| RefSeq identity: |
NM_206953 |
| Classification: |
PRAME family |
| Havana BLAST/BLAT: |
OTTHUMG00000151172 |